The utilization of immunohistochemical prognostic factor in endometrial adenocarcinoma: is it cost effective?

GÜRER, İNANÇ; Simsek, T; Erdogan, G; Atalay, E; Zorlu, CG; Karaveli, S; Erman, O

The utilization of immunohistochemical prognostic factor in endometrial adenocarcinoma: is it cost effective?

GÜRER İ. E., Simsek T., Erdogan G., Atalay E., Zorlu C., Karaveli S., ...Daha Fazla

EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, cilt.21, sa.2, ss.197-199, 2000 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 21 Sayı: 2
Basım Tarihi: 2000
Dergi Adı: EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.197-199
Anahtar Kelimeler: endometrial, adenocarcinoma, prognostic, PCNA, p53, Ki-67, UEA 1, c-erb B2, estrogen, progesterone, MALIGNANT ENDOMETRIUM, PROGESTERONE-RECEPTOR, EXPRESSION, CARCINOMA, P53
Akdeniz Üniversitesi Adresli: Evet

Özet

This study investigated the relation between immunohistochemical prognostic factors and clinical stage and histopathological grade in endometrial adenocarcinoma.